Amy M. Mason

6.4k total citations · 2 hit papers
72 papers, 2.6k citations indexed

About

Amy M. Mason is a scholar working on Genetics, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amy M. Mason has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 12 papers in Epidemiology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amy M. Mason's work include Genetic Associations and Epidemiology (33 papers), Nutrition, Genetics, and Disease (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Amy M. Mason is often cited by papers focused on Genetic Associations and Epidemiology (33 papers), Nutrition, Genetics, and Disease (7 papers) and Lipoproteins and Cardiovascular Health (6 papers). Amy M. Mason collaborates with scholars based in United Kingdom, Sweden and United States. Amy M. Mason's co-authors include Stephen Burgess, Susanna C. Larsson, Paul Carter, Shuai Yuan, Mathew Vithayathil, Siddhartha Kar, Jessica M. B. Rees, Karl Michaëlsson, Magnus Bäck and Christopher N. Foley and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Amy M. Mason

70 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study

2019 293 citations Susanna C. Larsson, Jessica M. B. Rees et al. profile →
Using genetic association data to guide drug discovery and development: Review of methods and applications

2023 60 citations Stephen Burgess, Amy M. Mason et al. profile →

Peers

Countries citing papers authored by Amy M. Mason

Since Specialization

Citations

This map shows the geographic impact of Amy M. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy M. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy M. Mason more than expected).

Fields of papers citing papers by Amy M. Mason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy M. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy M. Mason. The network helps show where Amy M. Mason may publish in the future.

Co-authorship network of co-authors of Amy M. Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Amy M. Mason. A scholar is included among the top collaborators of Amy M. Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy M. Mason. Amy M. Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alcohol consumption and risk of cancer: a Mendelian randomization analysis of four biobanks and consortium data 2025 ·BMC Medicine ·Susanna C. Larsson, Amy M. Mason, Héléne T. Cronjé, (unknown), (unknown), Siddhartha Kar, Stephen Burgess	0
2	Multi-biobank Mendelian randomization analyses identify opposing pathways in plasma low-density lipoprotein-cholesterol lowering and gallstone disease 2024 ·European Journal of Epidemiology ·Guoyi Yang, Amy M. Mason, Dipender Gill, C. Mary Schooling, Stephen Burgess	4
3	Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence 2023 ·Cardiovascular Research ·M. Nielsen, Yunus Çolak, Marianne Benn, Amy M. Mason, Stephen Burgess, Børge G. Nordestgaard	11
4	What makes a good life: using theatrical performance to enhance communication about polygenic risk scores research in patient and public involvement 2023 ·Journal of Community Genetics ·Amy M. Mason, (unknown), (unknown), Samuel A. Lambert, (unknown)	1
5	Elevated plasma adiponectin in risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: Observational and mendelian randomization studies 2023 ·Atherosclerosis ·M. Nielsen, Yunus Çolak, Marianne Benn, Amy M. Mason, Stephen Burgess, Børge G. Nordestgaard	1
6	Software Application Profile: SUMnlmr, an R package that facilitates flexible and reproducible non-linear Mendelian randomization analyses 2022 ·International Journal of Epidemiology ·Amy M. Mason, Stephen Burgess	11
7	Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations 2022 ·Arthritis Research & Therapy ·Shuai Yuan, Jie Chen, Xixian Ruan, Mathew Vithayathil, Siddhartha Kar, Xue Li, Amy M. Mason, Stephen Burgess, Susanna C. Larsson	12
8	Estimating the Population Benefits of Blood Pressure Lowering: A Wide‐Angled Mendelian Randomization Study in UK Biobank 2021 ·Journal of the American Heart Association ·(unknown), Amy M. Mason, Susanna C. Larsson, Dipender Gill, Claudia Langenberg, Stephen Burgess	14
9	Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study 2021 ·Journal of the American Heart Association ·Shuai Yuan, Stephen Burgess, Michael Laffan, Amy M. Mason, Martin Dichgans, Dipender Gill, Susanna C. Larsson	21
10	Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus 2021 ·Diabetologia ·Stephen Burgess, Rainer Malik, (unknown), Amy M. Mason, Marios K. Georgakis, Martin Dichgans, Dipender Gill	16
11	The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study 2021 ·PLoS Medicine ·Benjamin I. Perry, Stephen Burgess, Hannah Jones, Stanley Zammit, Rachel Upthegrove, Amy M. Mason, Felix R. Day, Claudia Langenberg, Nicholas J. Wareham, Peter B. Jones, Golam M. Khandaker	45
12	Older Women’s Experiences of a Community-Led Walking Programme Using Activity Trackers 2021 ·International Journal of Environmental Research and Public Health ·(unknown), Amy M. Mason, Marica Cassarino, Jason Chan, Annalisa Setti	8
13	Genetically predicted circulating B vitamins in relation to digestive system cancers 2021 ·British Journal of Cancer ·Shuai Yuan, Paul Carter, Mathew Vithayathil, Siddhartha Kar, Amy M. Mason, Stephen Burgess, Susanna C. Larsson	12
14	MR-Clust: clustering of genetic variants in Mendelian randomization with similar causal estimates 2020 ·Bioinformatics ·Christopher N. Foley, Amy M. Mason, Paul Kirk, Stephen Burgess	35
15	Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants 2020 ·PLoS Medicine ·Susanna C. Larsson, Paul Carter, Siddhartha Kar, Mathew Vithayathil, Amy M. Mason, Karl Michaëlsson, Stephen Burgess	115
16	Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort 2019 ·Molecular Psychiatry ·Golam M. Khandaker, Verena Zuber, Jessica M. B. Rees, Lívia A. Carvalho, Amy M. Mason, Christopher N. Foley, Apostolos Gkatzionis, Peter B. Jones, Stephen Burgess	179
17	Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation 2018 ·International Journal of Cardiology ·C. Mary Schooling, Shan Luo, Shiu Lun Au Yeung, Deborah J. Thompson, Savita Karthikeyan, (unknown), Amy M. Mason, Erik Ingelsson, Stephen Burgess	40
18	Mortality Risks Associated With Emergency Admissions During Weekends and Public Holidays: An Analysis of Electronic Health Records 2017 ·Obstetrical & Gynecological Survey ·A. Sarah Walker, Amy M. Mason, T. Phuong Quan, Nicola Fawcett, Peter Watkinson, Martin Llewelyn, Nicole Stoesser, John W. Finney, Jim Davies, David Wyllie, Derrick W. Crook, Tim Peto	5
19	Mortality risks associated with emergency admissions during weekends and public holidays: an analysis of electronic health records 2017 ·The Lancet ·A. Sarah Walker, Amy M. Mason, T. Phuong Quan, Nicola Fawcett, Peter Watkinson, Martin Llewelyn, Nicole Stoesser, John Finney, Jim Davies, David Wyllie, Derrick W. Crook, Tim Peto	98
20	The Degeneralization of the Generalized System of Preferences (GSP): Questioning the Legitimacy of the U.S. GSP 2004 ·Duke Law Journal ·Amy M. Mason	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact